Marc R Hammerman
Overview
Explore the profile of Marc R Hammerman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
324
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Hammerman M
Curr Opin Organ Transplant
. 2014 Feb;
19(2):131-2.
PMID: 24553503
No abstract available.
3.
Hammerman M
Curr Opin Organ Transplant
. 2014 Feb;
19(2):133-9.
PMID: 24535425
Purpose Of Review: Here, we review the rationale for the use of organs from embryonic donors, antecedent investigations and recent work from our own laboratory, exploring the utility for transplantation...
4.
Hammerman M
J Biomed Sci Eng
. 2013 Dec;
6(5A).
PMID: 24312695
Transplantation therapy for diabetes in humans is limited by the low availability of human donor whole pancreas or islets. Outcomes are complicated by immunosuppressive drug toxicity. Xenotransplantation is a strategy...
5.
Hu L, Chen J, Yang X, Senpan A, Allen J, Yanaba N, et al.
Magn Reson Med
. 2013 Aug;
71(6):2186-96.
PMID: 23929727
Purpose: We sought to develop a unique sensor-reporter approach for functional kidney imaging that employs circulating perfluorocarbon nanoparticles and multinuclear (1) H/(19) F MRI. Methods: (19) F spin density weighted...
6.
Hammerman M
Organogenesis
. 2012 Jun;
8(2):41-8.
PMID: 22699748
Transplantation therapy for diabetes is limited by unavailability of donor organs and outcomes complicated by immunosuppressive drug toxicity. Xenotransplantation is a strategy to overcome supply problems. Implantation of tissue obtained...
7.
Hammerman M
J Transplant
. 2011 Oct;
2011:261352.
PMID: 21969909
Transplantation therapy for diabetes is limited by unavailability of donor organs and outcomes complicated by immunosuppressive drug toxicity. Xenotransplantation is a strategy to overcome supply problems. Implantation of tissue obtained...
8.
Rogers S, Tripathi P, Mohanakumar T, Liapis H, Chen F, Talcott M, et al.
Organogenesis
. 2011 Jun;
7(3):154-62.
PMID: 21654197
Transplantation therapy for human diabetes is limited by the toxicity of immunosuppressive drugs. If toxicity can be minimized, there will still be a shortage of human donor organs. Xenotransplantation of...
9.
Hammerman M
J Transplant
. 2011 Jan;
2011:501749.
PMID: 21234246
Lack of donor availability limits the number of human donor organs. The need for host immunosuppression complicates transplantation procedures. Ultrastructurally precise kidneys differentiate in situ following xenotransplantation in mesentery of...
10.
Hammerman M
Organogenesis
. 2011 Jan;
6(4):270-5.
PMID: 21220963
Transplantation therapy for humans is limited by insufficient availability of donor organs and outcomes are complicated by the toxicity of immunosuppressive drugs. Xenotransplantation is a strategy to overcome supply problems....